Olathe-based Metactive lands $1.5M, two medical patents
March 21, 2017 | Meghan LeVota
Olathe-based medical device company Metactive released a pair of positive announcements for the firm.
Dr. Nick Franano
In addition to being awarded two patents, the firm closed on a $1.5 million Series A funding round — bringing its total raised to over $9 million. The round was co-led by the Mid-America Angels and an unnamed investor. Previously, the firm has engaged in partnerships with the Kansas Bioscience Authority and the National Institutes of Health.
Metactive Medical focuses on the creation of embolization devices that fights cancer. It’s latest, the Blockstent Microcatheter for embolization of peripheral arteries and veins and the Ballstent Microcatheter for embolization of cerebral aneurysms, are now patented.
CEO Nick Franano said that the issuance of these patents gives Metactive exclusive rights in the U.S. and international market. He added that the capital will help accelerate the firm.
“This new funding provides Metactive with the resources to continue the development and testing of its novel embolization devices,” Franano said in a release. “Our preclinical study results show that both devices routinely provide immediate, complete, and durable occlusion, something that market leading coils, flow diverting stents, and mesh vascular plugs can’t deliver. We look forward to a time when standing in the interventional suite wearing heavy lead protective garments, placing multiple devices, and performing serial angiography waiting for a vessel to occlude will no longer be required to complete an embolization procedure.”
Embolization is a treatment that blocks the flow of blood in specific segments of arteries and veins, enabling doctors to divert blood away from cancerous tumors and other abnormal tissues. More than 150,000 peripheral vascular embolization procedures are performed each year around the world using coils and vascular plugs, which can be difficult to use and often result in incomplete treatment.
Franano is also the CEO of Flow Forward Medical, which recently raised $1 million for its vascular health device.
Related Posts on Startland News
$12M capital infusion pumps Prairie Village-based Artio Medical to $46M in funding
A Johnson County medical device company announced Thursday the closing of an additional $12 million tranche of Series A financing — advancing the startup’s tech toward clinical study and commercialization with the backing of a leading Kansas City real estate developer. “We are thrilled to close this round of financing with strong support from existing investors…
Kansas City’s Top VC-Backed Companies in 2019
The Top Venture Capital-Backed Companies List recognizes the momentum pushing an emerging cohort of Kansas City growth-stage, venture-backed companies. Simply put, the list — updated and now published annually — shows a massive increase in venture capital deployed to Kansas City companies in 2019, as well as a significant jump in jobs at those businesses….
PHOTOS: Startland’s biggest event yet celebrates 2019 future newsmakers
Founders, investors and audience members were treated to a glimpse of their potential futures Thursday night during Startland’s Startups to Watch in 2019 celebration. The premier event — presented at the Copaken Stage by Kansas City-grown and headquartered H&R Block — showcased 12 companies featured on Startland’s recent list of the most anticipated newsmakers for…
2019 Startups to Watch: Metactive patience set to payoff for medical device patients
Editor’s note: Startland selected 12 Kansas City firms to spotlight for its annual Startups to Watch list. The following is one of 2019’s companies. Click here to view the full, ranked list of Startups to Watch. Metactive’s elevator pitch: Medical tech company that makes catheter-based devices used to treat cardiovascular disease, stroke, cancer, and life-threatening…